COPT Defense Properties (NYSE:CDP – Get Free Report) has received an average recommendation of “Moderate Buy” from the eight research firms that are presently covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $36.25.
CDP has been the subject of several research analyst reports. Truist Financial upped their price objective on COPT Defense Properties from $33.00 to $34.00 and gave the company a “hold” rating in a report on Monday, June 8th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of COPT Defense Properties in a report on Friday, July 17th. Evercore reiterated an “outperform” rating and issued a $42.00 price target on shares of COPT Defense Properties in a research report on Monday, July 27th. Wells Fargo & Company upped their price target on shares of COPT Defense Properties from $35.00 to $36.00 and gave the company an “overweight” rating in a report on Monday, June 1st. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $37.00 price objective on shares of COPT Defense Properties in a research report on Thursday, June 25th.
Check Out Our Latest Stock Analysis on CDP
Insider Activity at COPT Defense Properties
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in the business. Great Lakes Advisors LLC acquired a new stake in shares of COPT Defense Properties during the 2nd quarter valued at $217,000. Fiduciary Financial Group LLC acquired a new position in shares of COPT Defense Properties in the 2nd quarter worth $215,000. Handelsbanken Fonder AB grew its holdings in shares of COPT Defense Properties by 26.2% in the 2nd quarter. Handelsbanken Fonder AB now owns 46,681 shares of the company’s stock worth $1,699,000 after acquiring an additional 9,700 shares during the last quarter. GAMMA Investing LLC grew its holdings in shares of COPT Defense Properties by 20.9% in the 2nd quarter. GAMMA Investing LLC now owns 2,880 shares of the company’s stock worth $105,000 after acquiring an additional 498 shares during the last quarter. Finally, Edgestream Partners L.P. acquired a new stake in shares of COPT Defense Properties during the first quarter worth $1,831,000.
COPT Defense Properties Price Performance
NYSE CDP opened at $36.97 on Friday. COPT Defense Properties has a 12 month low of $27.06 and a 12 month high of $38.90. The company has a debt-to-equity ratio of 1.64, a current ratio of 2.89 and a quick ratio of 2.89. The firm has a market capitalization of $4.19 billion, a PE ratio of 25.67 and a beta of 0.76. The company’s 50 day simple moving average is $36.13 and its 200 day simple moving average is $33.27.
COPT Defense Properties (NYSE:CDP – Get Free Report) last announced its earnings results on Monday, July 27th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.33 by $0.07. The firm had revenue of $197.39 million for the quarter, compared to analysts’ expectations of $189.36 million. COPT Defense Properties had a return on equity of 10.48% and a net margin of 20.94%.During the same quarter in the previous year, the company earned $0.34 earnings per share. COPT Defense Properties has set its FY 2026 guidance at 1.390-1.430 EPS and its Q3 2026 guidance at 0.370-0.390 EPS. As a group, equities research analysts forecast that COPT Defense Properties will post 2.78 EPS for the current fiscal year.
About COPT Defense Properties
COPT Defense Properties (NYSE: CDP) is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.
The company’s portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.
See Also
- Five stocks we like better than COPT Defense Properties
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for COPT Defense Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for COPT Defense Properties and related companies with MarketBeat.com's FREE daily email newsletter.
